These may form the basis of a larger cohort study, formally profiling mucin expression along the oesophagus and stomach at consistent anatomical locations in patients with and without treatment for early and advanced OGC and pre-malignant conditions including Barrett’s metaplasia, as well as healthy controls and those with a benign disease such as GORD. The gene discussed is MUC5AC; the disease is Barrett esophagus.